| Cell line name |
CCH-OS-D |
|---|
| Synonyms |
CCH.OS.D |
|---|
| Accession |
CVCL_XG67 |
|---|
| Resource Identification Initiative |
To cite this cell line use: CCH-OS-D (RRID:CVCL_XG67) |
|---|
| Comments |
Derived from site: In situ; Bone; UBERON=UBERON_0002481. |
|---|
| Disease |
Osteosarcoma (NCIt: C9145)
Osteosarcoma (ORDO: Orphanet_668) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=22075555; DOI=10.1158/0008-5472.CAN-11-2778; PMCID=PMC3833671
Huang G.-X., Yu L., Cooper L.J.N., Hollomon M., Huls H., Kleinerman E.S.
Genetically modified T cells targeting interleukin-11 receptor alpha-chain kill human osteosarcoma cells and induce the regression of established osteosarcoma lung metastases.
Cancer Res. 72:271-281(2012) PubMed=22186140; DOI=10.1158/0008-5472.CAN-11-1460; PMCID=PMC3288434
Huang G.-X., Nishimoto K., Zhou Z.-C., Hughes D.P.M., Kleinerman E.S.
miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.
Cancer Res. 72:908-916(2012) PubMed=24136885; DOI=10.1002/pbc.24801; PMCID=PMC4154381
Guma S.R., Lee D.A., Yu L., Gordon N., Hughes D., Stewart J., Wang W.-L., Kleinerman E.S.
Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis.
Pediatr. Blood Cancer 61:618-626(2014) CLPUB00529
Lala N.
Characterization of ERBB4 expression in osteosarcoma.
Thesis MSc (2015); University of Texas Graduate School of Biomedical Sciences; Houston; USA |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q93445405
|
|---|
| Entry history |
|---|
| Entry creation | 06-Sep-2019 |
|---|
| Last entry update | 29-Jun-2023 |
|---|
| Version number | 6 |
|---|
